Cargando…

SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects

The burden of diabetic kidney disease (DKD) has increased worldwide in the last two decades. Besides the growth of diabetic population, the main contributors to this phenomenon are the absence of novel nephroprotective drugs and the limited efficacy of those currently available, that is, the inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garofalo, Carlo, Borrelli, Silvio, Liberti, Maria Elena, Andreucci, Michele, Conte, Giuseppe, Minutolo, Roberto, Provenzano, Michele, De Nicola, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630922/ https://www.ncbi.nlm.nih.gov/pubmed/31212638 http://dx.doi.org/10.3390/medicina55060268

Ejemplares similares

Nephroprotection by SGLT2 Inhibition: Back to the Future?
por: De Nicola, Luca, et al.
Publicado: (2020)

New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study
por: Minutolo, Roberto, et al.
Publicado: (2022)

Sodium Intake and Chronic Kidney Disease
por: Borrelli, Silvio, et al.
Publicado: (2020)

Independent Role of Underlying Kidney Disease on Renal Prognosis of Patients with Chronic Kidney Disease under Nephrology Care
por: De Nicola, Luca, et al.
Publicado: (2015)

Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials
por: Garofalo, Carlo, et al.
Publicado: (2018)

Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis
por: Garofalo, Carlo, et al.
Publicado: (2023)

Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report
por: Nappi, Felice, et al.
Publicado: (2019)

Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care
por: Borrelli, Silvio, et al.
Publicado: (2018)

Epidemiology of low-proteinuric chronic kidney disease in renal clinics
por: De Nicola, Luca, et al.
Publicado: (2017)

Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge
por: Provenzano, Michele, et al.
Publicado: (2021)

Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study
por: Minutolo, Roberto, et al.
Publicado: (2021)

Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects
por: Pafundi, Pia Clara, et al.
Publicado: (2021)

Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care
por: Provenzano, Michele, et al.
Publicado: (2018)

Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale
por: Provenzano, Michele, et al.
Publicado: (2019)

The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients
por: Provenzano, Michele, et al.
Publicado: (2020)

Resistant Hypertension in Nondialysis Chronic Kidney Disease
por: Borrelli, Silvio, et al.
Publicado: (2013)

Editorial: Management of Patients With Non-dialysis Dependent Chronic Kidney Disease (ND-CKD)
por: Provenzano, Michele, et al.
Publicado: (2022)

Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care
por: Borrelli, Silvio, et al.
Publicado: (2021)

SGLT inhibitors in type 1 diabetes: weighing efficacy and side effects
por: Janssens, Birgit, et al.
Publicado: (2020)

Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers
por: Borrelli, Silvio, et al.
Publicado: (2022)

Side Effects of Radiographic Contrast Media
por: Andreucci, Michele
Publicado: (2014)

Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed
por: Borrelli, Silvio, et al.
Publicado: (2021)

Epidemiology of CKD Regression in Patients under Nephrology Care
por: Borrelli, Silvio, et al.
Publicado: (2015)

Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile
por: Provenzano, Michele, et al.
Publicado: (2020)

Nephroprotection by SGLT2i in CKD Patients: May It Be Modulated by Low-Protein Plant-Based Diets?
por: Cupisti, Adamasco, et al.
Publicado: (2020)

The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
por: Provenzano, Michele, et al.
Publicado: (2020)

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs
por: Abassi, Zaid, et al.
Publicado: (2015)

Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease
por: Provenzano, Michele, et al.
Publicado: (2020)

OMICS in Chronic Kidney Disease: Focus on Prognosis and Prediction
por: Provenzano, Michele, et al.
Publicado: (2021)

Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
por: De Nicola, Luca, et al.
Publicado: (2022)

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
por: Giugliano, Dario, et al.
Publicado: (2020)

SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century?
por: Correale, Michele, et al.
Publicado: (2023)

Smoking habit as a risk amplifier in chronic kidney disease patients
por: Provenzano, Michele, et al.
Publicado: (2021)

Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis
por: Ielapi, Nicola, et al.
Publicado: (2020)

The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials
por: Garofalo, Carlo, et al.
Publicado: (2021)

RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study
por: Riccio, Eleonora, et al.
Publicado: (2022)

Side Effects of Radiographic Contrast Media: Pathogenesis, Risk Factors, and Prevention
por: Andreucci, Michele, et al.
Publicado: (2014)

Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery
por: Serraino, Giuseppe Filiberto, et al.
Publicado: (2021)

Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Renal Function Decline in Patients With Glomerular Diseases
por: Coppolino, Giuseppe, et al.
Publicado: (2020)

Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study
por: De Nicola, Luca, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3u9kqkpd2fepifcpj34gpuu90r